Industry n/a · SIC —
TAKEDA PHARMACEUTICAL CO LTD
TAK
Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $25.31B
- Enterprise value
- $25.31B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 2.0%
- 52-wk high
- $18.89
- 52-wk low
- $12.99
- Beta
- —
- Shares out
- 1.56B
5-year trend
About TAK
Business description and risk factors will appear here once TAK's latest filing is fully ingested.
Earnings tracker
Not enough quarterly history for TAK yet to draw an earnings tracker.
Industry trend
Industry · SIC —
Your notes
Keep private notes on TAK — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns TAK
Institutional value
$812.7M
Total shares held
45.0M
Distinct holders
257
-87 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Capital Research Global Investors | 19.1M | $353.8M | +5.6M (+41.7%) | Added |
| 2 | BlackRock, Inc. | 3.2M | $58.8M | +444.8K (+16.3%) | Added |
| 3 | UBS Group AG | 2.7M | $50.7M | -1.4M (-33.5%) | Trimmed |
| 4 | FIRST TRUST ADVISORS LP | 2.0M | $36.5M | -411.6K (-17.3%) | Trimmed |
| 5 | MANAGED ASSET PORTFOLIOS, LLC | 1.8M | $33.3M | +302.7K (+20.2%) | Added |
| 6 | ENVESTNET ASSET MANAGEMENT INC | 1.4M | $26.1M | +391.3K (+38.3%) | Added |
| 7 | WELLS FARGO & COMPANY/MN | 1.1M | $21.0M | +75.6K (+7.1%) | Added |
| 8 | Crossmark Global Holdings, Inc. | 777.1K | $14.4M | +32.0K (+4.3%) | Added |
| 9 | STIFEL FINANCIAL CORP | 628.5K | $11.6M | +74.3K (+13.4%) | Added |
| 10 | Creative Planning | 543.0K | $10.1M | +147.6K (+37.3%) | Added |
| 11 | Walleye Capital LLC | 521.6K | $9.7M | +438.6K (+527.8%) | Added |
| 12 | LPL Financial LLC | 474.2K | $8.8M | +117.8K (+33.0%) | Added |
| 13 | JPMORGAN CHASE & CO | 454.0K | $8.3M | +211.8K (+87.5%) | Added |
| 14 | Bleakley Financial Group, LLC | 431.6K | $8.0M | +68.8K (+19.0%) | Added |
| 15 | FEDERATED HERMES, INC. | 382.3K | $7.1M | +5.4K (+1.4%) | Added |
| 16 | QRG CAPITAL MANAGEMENT, INC. | 367.7K | $6.8M | +79.0K (+27.3%) | Added |
| 17 | CITIGROUP INC | 358.2K | $6.6M | +339.1K (+1778.2%) | Added |
| 18 | Ethic Inc. | 334.8K | $6.2M | +30.2K (+9.9%) | Added |
| 19 | Pathstone Holdings, LLC | 241.3K | $4.5M | +24.9K (+11.5%) | Added |
| 20 | Clean Yield Group | 238.4K | $4.4M | -22.4K (-8.6%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once TAK's latest filing finishes processing.